Literature DB >> 7769684

Inefficient complementation activity of poliovirus 2C and 3D proteins for rescue of lethal mutations.

N L Teterina1, W D Zhou, M W Cho, E Ehrenfeld.   

Abstract

Poliovirus (PV) 2C protein is a nonstructural polypeptide involved in viral RNA replication, whose biochemical activity(ies) in this process has not been defined. By using site-directed mutagenesis, it was shown previously that disruption of nucleotide-binding motifs present in this protein abolished viral RNA synthesis (C. Mirzayan and E. Wimmer, Virology 189:547-555, 1992; N. L. Teterina, K. M. Kean, E. Gorbalenya, V. I. Agol, and M. Girard, J. Gen. Virol. 73:1977-1986, 1992). We have tested whether PV 2C or 2BC protein provided in trans could rescue the replication of these mutated genomes. Rescuing proteins were provided either by cotransfection with helper chimeric PV-coxsackievirus genomes or by expression in cells with a vaccinia virus-T7 RNA polymerase transient-expression system. We report here that replication of mutated RNAs genomes was poorly supported in trans both by helper genomes and by expressed 2C or 2BC proteins. Similarly, very inefficient complementation was observed for two mutated genomes with lethal lesions in 3D polymerase coding sequence. Our results indicate that poliovirus RNA replication shows marked preference for proteins contributed in cis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769684      PMCID: PMC189162          DOI: 10.1128/JVI.69.7.4245-4254.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Replication of poliovirus RNA and subgenomic RNA transcripts in transfected cells.

Authors:  P S Collis; B J O'Donnell; D J Barton; J A Rogers; J B Flanegan
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  Cis-preferential replication of the turnip yellow mosaic virus RNA genome.

Authors:  J J Weiland; T W Dreher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

3.  Biochemical studies on poliovirus polypeptide 2C: evidence for ATPase activity.

Authors:  C Mirzayan; E Wimmer
Journal:  Virology       Date:  1994-02-15       Impact factor: 3.616

Review 4.  Genetics of poliovirus.

Authors:  E Wimmer; C U Hellen; X Cao
Journal:  Annu Rev Genet       Date:  1993       Impact factor: 16.830

5.  A poliovirus minireplicon containing an inactive 2A proteinase is expressed in vaccinia virus-infected cells.

Authors:  R Pal-Ghosh; C D Morrow
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

6.  Genetic studies on the poliovirus 2C protein, an NTPase. A plausible mechanism of guanidine effect on the 2C function and evidence for the importance of 2C oligomerization.

Authors:  E A Tolskaya; L I Romanova; M S Kolesnikova; A P Gmyl; A E Gorbalenya; V I Agol
Journal:  J Mol Biol       Date:  1994-03-11       Impact factor: 5.469

7.  Poliovirus protein 2C has ATPase and GTPase activities.

Authors:  P L Rodríguez; L Carrasco
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

8.  Studies of a putative amphipathic helix in the N-terminus of poliovirus protein 2C.

Authors:  A V Paul; A Molla; E Wimmer
Journal:  Virology       Date:  1994-02-15       Impact factor: 3.616

9.  Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells.

Authors:  M W Cho; N Teterina; D Egger; K Bienz; E Ehrenfeld
Journal:  Virology       Date:  1994-07       Impact factor: 3.616

10.  Poliovirus RNA synthesis utilizes an RNP complex formed around the 5'-end of viral RNA.

Authors:  R Andino; G E Rieckhof; P L Achacoso; D Baltimore
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

View more
  30 in total

1.  Initiation of poliovirus negative-strand RNA synthesis requires precursor forms of p2 proteins.

Authors:  Christy Jurgens; James B Flanegan
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming.

Authors:  Stefan Freigang; Denise Egger; Kurt Bienz; Hans Hengartner; Rolf M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

3.  Density-dependent selection in vesicular stomatitis virus.

Authors:  Isabel S Novella; Daniel D Reissig; Claus O Wilke
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

4.  Strand-specific RNA synthesis defects in a poliovirus with a mutation in protein 3A.

Authors:  Natalya L Teterina; Mario S Rinaudo; Ellie Ehrenfeld
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

5.  Stimulation of poliovirus synthesis in a HeLa cell-free in vitro translation-RNA replication system by viral protein 3CDpro.

Authors:  David Franco; Harsh B Pathak; Craig E Cameron; Bart Rombaut; Eckard Wimmer; Aniko V Paul
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Viable polioviruses that encode 2A proteins with fluorescent protein tags.

Authors:  Natalya L Teterina; Eric A Levenson; Ellie Ehrenfeld
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

7.  trans-encapsidation of a poliovirus replicon by different picornavirus capsid proteins.

Authors:  X Y Jia; M Van Eden; M G Busch; E Ehrenfeld; D F Summers
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

8.  trans-Complementation of flavivirus RNA polymerase gene NS5 by using Kunjin virus replicon-expressing BHK cells.

Authors:  A A Khromykh; M T Kenney; E G Westaway
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

9.  Rescue of defective poliovirus RNA replication by 3AB-containing precursor polyproteins.

Authors:  J S Towner; M M Mazanet; B L Semler
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

10.  Reversible dissociation of the poliovirus replication complex: functions and interactions of its components in viral RNA synthesis.

Authors:  D Egger; L Pasamontes; R Bolten; V Boyko; K Bienz
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.